J5A,P 24.9, Jgem 11.7, J5A,3A 3.7 Hz, 5A-H), 4.47 (t, J 6.6 Hz, 2 3 CH2-npeoc),
4.50–4.55 (m, 5A-H), 4.59 (ddd, J5A,P 19.2, Jgem 10.3, J5A,4A 4.2 Hz, 5A-H), 6.02
(t, J1A,2A 5.9 Hz, 1A-H), 6.09 (t, J1A,2A 6.6 Hz, 1A-H), 7.20–7.27 (m, 2 3 5-H,
4 3 Ar), 7.38 (t, J 7.7 Hz, 6 3 Ar), 7.46 (d, J 8.8 Hz, 4 3 Ar npeoc), 7.95
(d, J6,5 7.7 Hz, 6-H), 7.99 (d, J6,5 7.3 Hz, 6-H) and 8.19 (d, J 8.8 Hz, 4 3
Ar npeoc); dC (100.4 MHz, CDCl3 and CD3OD) 34.8 (CH2-npeoc), 35.7 (C-
2A), 36.6 (C-2A), 42.7 (C-3A), 42.8 (C-3A), 62.4 (C-6A), 65.0 (C-6A), 65.4 (CH2-
npeoc), 67.2 (C-5A), 68.4 (C-5A), 81.5 (C-4A), 84.4 (C-4A), 88.3 (C-1A), 88.7
(C-1A), 119.7 (2 3 C-5), 123.6 (Ar), 123.8 (Ar), 125.7 (Ar), 129.8 (Ar),
142.8 (Ar), 142.9 (Ar), 143.3 (C-6), 143.4 (C-6), 145.2 (C–NO2), 146.9 (C-
quart), 150.0 (C-quart), 152.8 (2 3 C-4), 155.6 (2 3 CNO, npeoc) and 163.2
(2 3 C-2).
For the b-anomer of 12: dH (400 MHz, CDCl3), integration values for the
discrete diastereoisomers have not been given but were in the approximate
ratio of 5:1 with respect to the signals for the discrete diastereoisomers,
2.29–2.43 (m, 4 3 2-HA), 2.56–2.64 (m, 2 3 3-HA), 3.11 (t, J 6.6 Hz, 2 3
CH2-npeoc), 4.09 (dd, Jgem 12.8, J6A,3A 10.3 Hz, 6A-H), 4.14–4.24 (m, 3 3 6A-
H), 4.32 (dd, Jgem 11.7, J5A,4A 3.7 Hz, 5A-H), 4.34–4.42 (m, 2 3 4A-H, 5A-H),
4.45 (t, J 6.6 Hz, 2 3 CH2-npeoc), 4.49–4.58 (m, 5A-H), 4.67 (ddd, J5A,P 18.3,
Jgem 10.6, J5A,4A 4.4 Hz, 5A-H), 6.05 (dd, J1A,2A 6.8, J1A,2A 1.6 Hz, 1A-H), 6.12 (d,
J1A,2A 7.0 Hz, 1A-H), 7.22 (d, J 7.7 Hz, 4 3 Ar), 7.32–7.38 (m, 2 3 5-H, 6 3
Ar), 7.41 (d, J 8.4 Hz, 4 3 Ar npeoc), 7.76 (d, J6,5 7.3 Hz, 6-H), 7.89 (d, J6,5
6.6 Hz, 6-H) and 8.17 (d, J 8.4 Hz, 4 3 Ar npeoc); dP (81 MHz, CDCl3)
25.2 and 25.7; m/z 572.1294 (M+) (C25H25N4O10P requires 572.1308).
‡ We thank A. Jahans and Dr M. G. B. Drew for the X-ray structure
determination, which will be described in detail elsewhere. Suffice to say,
the compound crystallised in an extended conformation.
§ Selected spectroscopic data for 13: dH (400 MHz, CD3OD), integration
values for the discrete diastereoisomers have not been given but were in the
approximate ratio of 2:1 with respect to the signals for the discrete
diastereoisomers, 2.16–2.21 (m, 4 3 2-HA), 2.71–2.78 (m, 2 3 3-HA), 4.0
(dd, J5A,P 20.9, Jgem 11.0 Hz, 5A-H), 4.05–4.17 (m, 2 3 4A-H, 2 3 5A-H), 4.23
(ddd, J6A,P 22.3, Jgem 10.3, J6A,3A 8.2 Hz, 6A-H), 4.32–4.44 (m, 3 3 6A-H), 4.49
(ddd, J5A,P 20.0, Jgem 10.3, J5A,4A 3.9 Hz, 5A-H), 5.81 (d, J5,6 7.7 Hz, 5-H), 5.83
(d, J5,6 7.7 Hz, 5-H), 5.99 (dd, J1A,2A 6.6, J1A,2A 3.7 Hz, 1A-H), 6.03 (dd, J1A,2A
6.9, J1A,2A 2.9 Hz, 1A-H), 7.15 (t, J 7.9 Hz, 6 3 Ar), 7.30 (t, J 7.9 Hz, 4 3 Ar),
7.57 (d, J 7.7 Hz, 6-H) and 7.59 (d, J 7.7 Hz, 6-H); m/z 380.1011 [(M + H)+]
(C16H19N3O6P requires 380.1011).
possible using base (1% NaOH in MeOH) and the free hydroxy
was selectively phosphorylated using a modification of the
method of Uchiyama et al.5 This involved reaction of the
nucleoside with 1 equiv. of tert-butylmagnesium chloride in the
presence of diphenylphosphorochloridate to produce the de-
sired 6A-diphenylphosphate 8 (63% yield). We had hoped to
convert this compound into the cyclic phosphate 9, but despite
considerable efforts, this goal eluded us.
We thus turned our attention to the bis-silylated adduct 5b
which was reduced (DIBAL-H) and derivatised to provide
lactol esters 6b and thence the protected nucleoside anomers 7b
(52% overall). Protection of the free amino group of the
cytosine as its 2-(p-nitrophenyl)ethyl carbamate6 yielded the
fully-protected nucleoside anomers 10, and to our delight the
anomers could now be separated (with relative ease) by flash
chromatography. (Indeed we have used this protecting group to
facilitate separation of anomeric mixtures of several substituted
cytidines.) The silyl ether groups of these individual anomers
were now removed (toluene-p-sulfonic acid in MeOH) and the
resultant diols 11 were reacted in pyridine with bis(benzotri-
azolyl)phenyl phosphate7 (from 2 equiv. of 1-hydroxy-
benzotriazole and phenylphosphodichloridate in the presence of
triethylamine), to produce the desired cyclic phosphates 12
(35% a and 31% b after chromatography.† The a-anomer was
more easily recrystallised than the b-anomer, and an X-ray
crystallographic study confirmed the structure of this com-
pound.‡ Finally, the carbamate group was removed from the b-
anomer using triethylamine to yield the novel homo-cyclic
nucleotide 13,§ which was submitted for biological evaluation.
We had hoped that the compound would act as a prodrug from
compound 2 (B = cytosine), a compound with good activity
against several viruses.3 It did in fact show modest activity
against HIV-1 (EC50 350 mmolar) and is presently being
evaluated in other systems.
All of the reactions as far as compound 11 have been carried
out routinely on the half-gram scale (though the cyclic
phosphate formation has only been accomplished thus far on the
100 mg scale). One obvious extension of this work is to replace
the phenyl group with other aryl groups or by S-acyl-2-thioethyl
groups as in prodrugs like 1, in an attempt to improve the
bioavailability of the compounds. However, given the pivotal
importance of cyclic-3A,5A-AMP and -GMP in biological
processes, a more urgent task is to extend this methodology to
the purine series in order to make homologues of these very
important compounds.
J. G. thanks the MRC for a studentship under the AIDS
Initiative Programme and we thank Dr Naheed Mahmood
(MRC) for the (ongoing) biological evaluation. We are also
very grateful for the advice given by Professor Colin Reese and
for the numerous FAB mass spectra provided by the EPSRC
Mass Spectrometry Centre at the University of Swansea.
References
1 J. W. Beach, L. S. Jeong, A. J. Alves, D. Pohl, H. O. Kim, C.-N. Chang,
S.-L. Doong, R. F. Schirazi, Y.-C. Cheng and C. K. Chu, J. Org. Chem.,
1992, 57, 2217; T.-S. Lin, M.-Z. Luo, M.-C. Liu, Y.-L. Zhu, E. Gullen,
G. E. Dutschman and Y.-C. Cheng, J. Med. Chem., 1996, 39, 1757;
T.-S. Lin, M.-Z. Luo and M.-C. Liu, Tetrahedron, 1995, 51, 1055; T.-
S. Lin, M.-Z. Luo, M.-C. Liu, S. B. Pai, G. E. Dutschman and Y.-
C. Cheng, J. Med. Chem., 1994, 37, 798.
2 X. Pannecouke, G. Parmentier, G. Schmitt, F. Dolle and B. Luu,
Tetrahedron, 1994, 50 1173; I. Lefebre, C. Perigaud, A. Pompon,
A.-M. Aubertin, J.-L. Girardet, A. Kirn, G. Gosselin and J.-L. Imbach,
J. Med. Chem., 1995, 38, 3941; C. McGuigan, R. N. Pathirana,
J. Balzarini and E. De Clerq, J. Med. Chem., 1993, 36, 1048;
C. McGuigan, R. N. Pathirana, M. P. H. Davies, J. Balzarini and E. De
Clerq, Bioorg. Med. Chem. Lett., 1994, 4, 427.
3 J. Mann and A. C. Weymouth-Wilson, J. Chem. Soc., Perkin Trans. 1,
1994, 3141.
4 J. Mann and A. C. Weymouth-Wilson, Synlett, 1992, 67.
5 M. Uchiyama, Y. Aso, R. Noyori and Y. Hayakawa, J. Org. Chem., 1993,
58, 373.
6 F. Himmelsbach, B. S. Schulz, T. Trichtinger, R. Charubala and
W. Pfleiderer, Tetrahedron, 1984, 40, 59.
Footnotes
† Selected spectroscopic data for the a-anomer of 12: dH (400 MHz, CDCl3
and CD3OD), integration values for the discrete diastereoisomers have not
been given but were in the approximate ratio of 2:1 with respect to the
signals for the discrete diastereoisomers, 1.75–1.84 (m, 2 3 2A-H),
2.45–2.51 (m, 2A-H), 2.80–2.87 (m, 2 3 3A-H), 2.93–2.99 (m, 2A-H), 3.14 (t,
J 6.6 Hz, CH2-npeoc), 3.51 (dd, Jgem 11.0, J6A,3A 6.6 Hz, 6A-H), 3.59 (dd, Jgem
11.0, J6A,3A 5.1 Hz, 6A-H), 3.76 (dd, Jgem 11.0, J6A,3A 4.4 Hz, 6A-H), 3.82 (dd,
Jgem 11.0, J6A,3A] 4.0 Hz, 6A-H), 4.12–4.25 (m, 5A-H, 2 3 4A-H), 4.40 (ddd,
7 G. van der Marel, C. A. A. van Boeckel, G. Wille and J. H. van Boom,
Tetrahedron Lett., 1981, 22, 3887.
Received, 12th November 1996; Com. 6/07699H
244
Chem. Commun., 1997